<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00061828</url>
  </required_header>
  <id_info>
    <org_study_id>PROBE Study - ChiLDReN Network</org_study_id>
    <secondary_id>U01DK103149</secondary_id>
    <secondary_id>U01DK103140</secondary_id>
    <secondary_id>U01DK103135</secondary_id>
    <secondary_id>U01DK084575</secondary_id>
    <secondary_id>U01DK084538</secondary_id>
    <secondary_id>U01DK084536</secondary_id>
    <secondary_id>U01DK062503</secondary_id>
    <secondary_id>U01DK062500</secondary_id>
    <secondary_id>U01DK062497</secondary_id>
    <secondary_id>U01DK062481</secondary_id>
    <secondary_id>U01DK062470</secondary_id>
    <secondary_id>U01DK062466</secondary_id>
    <secondary_id>U01DK062456</secondary_id>
    <secondary_id>U01DK062453</secondary_id>
    <secondary_id>U01DK062452</secondary_id>
    <secondary_id>U01DK062445</secondary_id>
    <secondary_id>U01DK062436</secondary_id>
    <nct_id>NCT00061828</nct_id>
  </id_info>
  <brief_title>PROBE: A Prospective Database of Infants With Cholestasis</brief_title>
  <acronym>PROBE</acronym>
  <official_title>Childhood Liver Disease Research and Education Network (CHILDREN): A Prospective Database of Infants With Cholestasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arbor Research Collaborative for Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Arbor Research Collaborative for Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and
      hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary
      Atresia Research Consortium (BARC) is to establish a database of clinical information and
      serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal
      hepatitis (INH) to facilitate research and to perform clinical, epidemiological and
      therapeutic trials in these two important pediatric liver diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center project to establish a prospective database of clinical information
      and a repository of blood and tissue samples from children with diagnoses of neonatal liver
      diseases, such as biliary atresia and neonatal hepatitis, in order to perform research in
      these important liver problems. Children will be screened and enrolled at presentation at the
      participating pediatric liver sites. Subjects diagnosed with biliary atresia will be followed
      intensively for the first year, at 18 months of age, and then annually up to 15 years of age.
      Other subjects diagnosed with cholestasis will be followed on the same schedule; if there is
      complete (clinical and biochemical) resolution of their underlying liver disease off all
      therapy, there will be one follow up visit within one year (preferably scheduled at the time
      of the next planned follow up visit or at 12 months of age, whichever is later) for data
      collection and to obtain blood samples. The development of a serum and tissue bank of
      specimens from children with various neonatal cholestatic disorders will be an invaluable
      tool for current and future investigations into the etiology and pathogenesis of
      hepatobiliary injury in the infant.

      Detailed clinical data, laboratory investigations, liver biopsy specimens, and long-term
      follow-up of outcomes are part of the normal standard of care with respect to the diagnosis
      and treatment of the subjects with liver problems. This research involves the collection of
      diagnostic, clinical and outcome data concerning the subject, which is kept without
      identification (coded) in a national research database of infants with liver disease. Samples
      of blood and urine will be obtained for later research analysis, whenever possible, at the
      time of clinically indicated blood draws or when there is IV access for a clinical procedure.
      When liver biopsy specimens are obtained for diagnostic purposes, any liver biopsy specimen
      in excess of that needed for diagnostic use will be sent to the tissue repository. When a
      portoenterostomy or liver transplant occurs, sections of the liver, biliary remnant and bile
      specimens, if removed in the course of surgery and in excess of that needed for diagnostic
      use, will be sent for the repository. These specimens will be used in investigations into the
      mechanisms and causes of the liver damage that occur in the subject's condition. As part of
      the standard of care, the study will follow-up and record progress of the liver problem by
      routine clinical examinations and laboratory tests for up to 15 years. All data from this
      study will be kept in a secure research database at the data coordinating center.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in disease severity over time (disease progression)</measure>
    <time_frame>Measured at baseline, 1month, 2 months, 3, 6 months post-baseline, 12 and 18 months of age, then annually through year 15.</time_frame>
    <description>disease progression defined by transplant date, date of death, worsening liver function, and complications related to worsening liver function</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Biliary Atresia</condition>
  <condition>Cholestasis</condition>
  <arm_group>
    <arm_group_label>Biliary Atresia</arm_group_label>
    <description>Infants presenting with cholestasis who are diagnosed with biliary atresia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Biliary Atresia</arm_group_label>
    <description>Infants presenting with cholestasis without a diagnosis of biliary atresia.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples of blood, urine and liver tissue samples will be collected for research purposes.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study population will be selected from the patient base of participating speciality
        care clinics.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          -  Infant's age less than or equal to 180 days at initial presentation at the ChiLDREN
             clinical site.

          -  Diagnosis of cholestasis defined by serum direct or conjugated bilirubin greater than
             20% of total and greater than or equal to 2 mg/dl.

          -  The subject's parent(s)/guardian(s) willing to provide informed written consent.

        EXCLUSION CRITERIA

          -  Acute liver failure.

          -  Previous hepatobiliary surgery with dissection or excision of biliary tissue.

          -  Diagnoses of bacterial or fungal sepsis (except where associated with metabolic liver
             disease)

          -  Diagnoses of hypoxia, shock or ischemic hepatopathy within the past two weeks (If the
             cholestasis persists beyond two weeks of the initiating event, the infant can be
             enrolled).

          -  Diagnosis of any malignancy.

          -  Presence of any primary hemolytic disease (except when diagnosed with biliary atresia
             or another cholestatic disease being studied by ChiLDREN).

          -  Diagnosis of any drug or TPN-associated cholestasis (except when diagnosed with
             biliary atresia or another cholestatic disease being studied by ChiLDREN).

          -  Diagnosis with ECMO-associated cholestasis.

          -  Birth weight less than 1500g (except when diagnosed with biliary atresia).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Sokol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital Colorado</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ed Doo, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Magee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan Medical Center, Ann Arbor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Merion, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arbor Research Collaborative of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Averell Sherker, MD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peg Hill-Callahan, BS</last_name>
    <phone>734 369-9674</phone>
    <email>peg.hill-callahan@arborresearch.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joanne Lord, CCRC</last_name>
    <phone>734 369-9965</phone>
    <email>joanne.lord@arborresearch.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Goodhue, CPNP</last_name>
      <phone>323-361-4566</phone>
      <email>cgoodhue@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Kasper Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nanda Kerker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonia Michail, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danny Thomas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Hite</last_name>
      <phone>720-777-4690</phone>
      <email>michelle.hite@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Darci Anderson</last_name>
      <phone>720-777-9911</phone>
      <email>darci.anderson@childrenscolorado.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Sokol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cara Mack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Narkewicz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shikha Sundaram, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta (Emory University)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Tory</last_name>
      <phone>404-785-1467</phone>
      <email>rita.tory@choa.org</email>
    </contact>
    <investigator>
      <last_name>Saul Karpen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nitika Gupta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rene Romero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Vos, MD MSPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Kelly, RN, BSN</last_name>
      <phone>312-227-3523</phone>
      <email>skelly@luriechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Mary Riordan, CCRP</last_name>
      <phone>312-227-4558</phone>
      <email>mriordan@luriechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Estella Alonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lee Bass, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Sawyers, BSRT</last_name>
      <phone>317-944-1421</phone>
      <email>clsawyer@iupui.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ann Klipsch, RN</last_name>
      <phone>317-944-9605</phone>
      <email>aeye@iupui.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jean Molleston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Molly Bozic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Denlinger</last_name>
      <phone>513-636-7818</phone>
      <email>julie.denlinger@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Kelly Gindling</last_name>
      <phone>513-803-7482</phone>
      <email>kelly.gindling@cchmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jorge Bezerra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Heubi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Miethke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Palermo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessi Erlichman, MPH</last_name>
      <phone>215-590-2525</phone>
      <email>erlichman@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Wong</last_name>
      <phone>267-426-8412</phone>
      <email>skwong@email.chop.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kathleen Loomes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth Rand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Piccoli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Bukauskas</last_name>
      <phone>412-692-7703</phone>
      <email>kathryn.bukauskas@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Squires, Jr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Veena Venkat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Tsai, MPH</last_name>
      <phone>832-822-3634</phone>
      <email>tc2@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Paula Hertel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Shneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Rutherford</last_name>
      <phone>801-585-9495</phone>
      <email>ann.rutherford@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Guthery, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyle Jensen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Young</last_name>
      <phone>206-987-1037</phone>
      <email>melissa.young@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Karen Murray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Horslen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelyn Shu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Simoes</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>201594</phone_ext>
      <email>vaness.simoes@sickkids.ca</email>
    </contact>
    <contact_backup>
      <last_name>Elena Reydman</last_name>
      <phone>416-813-7654</phone>
      <phone_ext>201594</phone_ext>
      <email>elena.reydman@sickkids.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Vicky Ng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Binita Kamath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.childrennetwork.org</url>
    <description>Childhood Liver Disease Research Network</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2003</study_first_submitted>
  <study_first_submitted_qc>June 5, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2003</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be transferred to NIDDK at the end of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

